GLP-1 medications are everywhere right nowbut what do they actually do, who benefits most, and how are they changing conversations around womens health, aging, metabolism, and self-image
COURAGE Trial confirms potential to improve the quality of semaglutide-induced weight loss by preserving lean mass owenhaskins Jun 3, 2025 3 min read Interim results from the ongoing Phase 2 COURAGE trial - investigating novel combinations of semaglutide (GLP-1 receptor agonist) and trevogrumab (anti-GDF8/anti-myostatin) with or without garetosmab (anti-activin A) for the treatment of obesity - demonstrated that approximately 35% of semaglutide-induced weight loss was due to loss of lean mass
How the Five Providers Stack Up With evolving regulatory changes in the compounded semaglutide space, it can be hard to get clear on the best telehealth platform or provider
The aromatic side chain of Y31 of IGF1 is sandwiched between P5 in the L1 domain and P256 in the CRD, and is further surrounded by several other conserved hydrophobic residues in the CRD, including F241, F251, and I255 (Fig
Effects of a multi-vitamin/mineral supplement on cognitive function and fatigue during extended multi-tasking
As symptoms of dementia start to appear, leaving appliances on can become a common occurrence